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P
neumonia is the most commonly reported nosocomial infection among ICU patients, occurring predominately in individuals requiring mechanical ventilation, at a rate of 1 to 3% per day of mechanical ventilation. 1 The estimated prevalence of nosocomial pneumonia (NP) within the ICU setting ranges from 10 to 65%, with case fatality rates Ͼ 20% in most reported studies. [2] [3] [4] Despite improvements in the diagnosis, treatment, and prevention of NP, it remains an important cause of hospital mortality. 5, 6 The management of NP is often based on the timing of its occurrence in relation to the start of mechanical ventilation or ICU admission. 7 This is due to reported differences among the pathogens associated with early-onset NP (ie, occurring within 48 to 96 h of ICU admission) compared to late-onset NP (ie, occurring Ͼ 48 to 96 h after ICU admission). 8 Early-onset NP is most often reported to be due to antibiotic-sensitive pathogens including Haemophilus influenza, oxacillin-sensitive Staphylococcus aureus (OSSA), and Streptococcus pneumonia, while late-onset NP is frequently attributed to antibioticresistant pathogens such as oxacillin-resistant S aureus (ORSA), Pseudomonas aeruginosa, Acinetobacter species, and Enterobacter species. 8, 9 A systematic comparison of risk factors, pathogens, and clinical outcomes between early-onset and late-onset NP in the ICU setting has not been previously reported. Therefore, we performed a prospective cohort study with three goals. First, we wanted to determine the magnitude of the problem of earlyonset and late-onset NP among critically ill adult patients. Second, we sought to identify potential risk factors associated with NP in each group of patients. Third, we set out to evaluate the relationship between hospital mortality and NP. It was our hope that such data would provide useful information for the clinical management of patients at risk for NP and those developing NP.
Materials and Methods

Study Location and Patients
The study was conducted at a university-affiliated urban teaching hospital: Barnes-Jewish Hospital (1,200 beds) in St. Louis, MO. During a 17-month period (July 1997 to November 1998), all patients admitted to the medical ICU (19 beds) and surgical ICU (18 beds) were potentially eligible for this investigation. Patients were excluded if they were transferred to the medical or surgical ICU temporarily due to lack of available beds in one of the other hospital ICUs. Patients were entered into the study if they were Ͼ 18 years old. This study was approved by the Washington University School of Medicine Human Studies Committee.
Study Design and Data Collection
One of the investigators made daily rounds in the medical and surgical ICU to identify eligible patients and record relevant data from patients' medical records, bedside flow sheets, computerized bedside nursing stations (EMTEK Health Care Systems; Tempe, AZ), computerized radiographic reports, and reports of microbiological studies (sputum Gram's stains and sputum, blood, and pleural fluid cultures). Study patients were prospectively followed for the occurrence of early-onset and late-onset NP until they were successfully treated and discharged from the hospital or until death. All patients with suspected early-onset and late-onset NP were prospectively and independently reviewed by one of the investigators (MHK), who confirmed the diagnosis of NP based on predetermined criteria (see below). Patients could not be entered into the study more than once, and only the first episode of NP was evaluated.
For all study patients, the following characteristics were prospectively recorded at the time of study entry: age, gender, concomitant diseases, hospital admitting diagnosis, indication for mechanical ventilation, the ratio of Pao 2 /fraction of inspired oxygen (Fio 2 ), severity of illness based on APACHE II (acute physiology and chronic health evaluation), 10 and the patient's diagnostic category (medical vs surgical). Specific processes of medical care examined during the period of ICU admission as potential risk factors for the development of NP included the administration of antacids, histamine type-2 receptor antagonists, sucralfate, corticosteroids, or vasopressors, tracheostomy, dialysis, reintubation, the presence of central venous or urinary tract catheters and their duration, and mechanical ventilation and its duration. In addition to the occurrence of early-onset or lateonset NP, secondary outcomes evaluated included hospital mortality, the lengths of ICU and hospital stay, and the number of acquired organ system derangements.
Definitions
All definitions were selected prospectively as part of the original study design. APACHE II scores were calculated based on clinical data available from the first 24 h of ICU admission. Acquired organ system derangements were defined using the modified criteria of Rubin and coworkers. 11 One point was given for acquired dysfunction of each organ system using the following definitions: renal, a twofold increase in the baseline creatinine level by 2.0 mg/dL (176.8 mol/L); hepatic, a rise in the total bilirubin level to Ͼ 2.0 mg/dL (34.2 mol/L); pulmonary, requiring mechanical ventilation for a diagnosis of pneumonia, COPD, asthma, pulmonary edema (cardiogenic or noncardiogenic), a Pao 2 Ͻ 60 mm Hg while receiving an Fio 2 Ն 0.50, or the use of 10 cm H 2 O or more of positive end-expiratory pressure; hematologic, the presence of disseminated intravascular coagulation, WBC count Ͻ 1,000 cells/L (1.0 ϫ 10 9 cells/L), or platelet count Ͻ 75 ϫ 10 3 /L (75 ϫ 10 9 /L); neurologic, new focal deficit (eg, hemiparesis following cerebral infarction) or new generalized process (eg, seizures or coma); GI, GI hemorrhage requiring transfusion, or new ileus or diarrhea lasting Ͼ 24 h and unrelated to prior bowel surgery; and cardiac, acute myocardial infraction, cardiac arrest, or the new onset of congestive heart failure.
The diagnostic criteria for NP used in this study were modified from those established by the American College of Chest Physicians. 12 Early-onset NP (ie, NP occurring within the first 96 h of ICU admission) and late-onset NP (ie, NP occurring after the first 96 h of ICU admission) were prospectively defined as the occurrence of new and persistent radiographic infiltrates in conjunction with one of the following: positive pleural/blood cultures for the same organism as that recovered in the tracheal aspirate or sputum; radiographic cavitation; histopathologic evidence of pneumonia; or two of the following: fever, leukocytosis, and purulent tracheal aspirate or sputum. Persistence of an infiltrate was defined as having the infiltrate present radiographically for at least 72 h. Fever was defined as an increase in the core temperature Ն 1°C and a core temperature Ͼ 38.3°C. Leukocytosis was defined as a 25% increase in the circulating leukocytes from the baseline admission value and a value Ͼ 10 ϫ 10 3 /L (10 ϫ 10 9 /L). Tracheal aspirates were considered purulent if abundant neutrophils were present per high-power field using Gram's stain (ie, Ͼ 25 neutrophils per high-power field). Additionally, when available, bronchoscopic and nonbro-nchoscopic BAL cultures with appropriate quantitative thresholds were employed to support the diagnosis of NP. 13 Hospital mortality was defined as those patient deaths occurring during the initial hospital admission during which they were studied.
Statistical Analysis
Univariate analysis was used to compare variables for the outcome groups of interest. Comparisons were unpaired, and all tests of significance were two tailed. Continuous variables were compared using Student's t test for normally distributed variables and Wilcoxon's rank sum test for nonnormally distributed variables. The 2 statistic or Fisher's Exact Test were used to compare categorical variables. The primary data analysis compared patients with early-onset NP to patients with late-onset NP, and both were compared to patients without NP. We confirmed the results of these tests, while controlling for specific patient characteristics and severity of illness (Tables 1, 2) , with multiple logistic regression analysis 14 using a commercial statistical package. 15 Multivariate analysis was performed using models that were judged a priori to be clinically sound. This was necessary to avoid producing spuriously significant results with multiple comparisons. 16 Potential risk factors for NP (eg, re-intubation, antacids, tracheostomy) were required to be present prior to the development of NP in order to be included in the multivariate analysis. Similarly, the duration of exposure to a specific risk factor (eg, mechanical ventilation) only included the time period prior to the occurrence of NP. A stepwise approach was used for entering new terms into the model with 0.05 as the limit for their acceptance or removal. Model overfitting was examined for by evaluating the ratio of outcome events to the total number of independent variables in the final model, and specific testing for interactions between the individual variables was included in our analysis. As originally planned, a second multivariate analysis was performed examining hospital mortality as the dependent outcome variable. Results of the logistic regression analyses are reported as adjusted odds ratios (AORs) with their 95% confidence intervals (CIs). All values are expressed as the mean Ϯ SD (continuous variables), or as a percentage of the group they were derived from (categorical variables). All p values Յ 0.05 were considered to indicate statistical significance.
Results
Patients
A total of 3,668 consecutive eligible patients were prospectively evaluated ( Table 1 ). The mean age of the patients was 57.7 Ϯ 18.4 years (range, 13 to 111 years), and the mean APACHE II score was 17.3 Ϯ 8.4 (range, 1 to 53). One thousand seven hundred sixty-two patients (48.0%) were women, and 1,906 patients (52.0%) were men. Four hundred twenty patients (11.5%) developed NP; 235 patients (6.4%) developed early-onset NP, whereas 185 patients (5.0%) developed late-onset NP. Univariate analysis of the baseline demographic factors of the study cohort demonstrated that the presence of COPD, lower serum levels of albumin, lower Pao 2 / Fio 2 ratios, and increasing APACHE II scores were significantly associated with both early-onset and late-onset NP as compared to the absence of NP. Lower serum albumin levels and a lower incidence of malignancy were significantly more common in patients with late-onset NP as compared to those with early-onset NP. Patients with late-onset NP were significantly more likely to be male, compared to patients without NP.
Nosocomial Pneumonia
Univariate analysis demonstrated that there were significant differences in the processes of care between patients with and without NP ( Table 2) . Undergoing tracheostomy, reintubation, the use of antacids, histamine type-2 receptor antagonists, sucralfate, or vassopressors, the presence of a urinary tract catheter and its duration, central venous catheter and its duration, and mechanical ventilation and its duration were significantly associated with the development of either early-onset NP or late-onset NP. Undergoing surgery prior to ICU admission, tracheostomy, the use of antacids, histamine type-2 receptor antagonists, sucralfate, or vasopressors, the duration of urinary tract catheterization, central venous catheterization and its duration, and mechanical ventilation and its duration were significantly greater among patients developing late-onset NP as compared to early-onset NP.
Patients developing early-onset NP were significantly more likely to be hospitalized for at least 24 h prior to ICU admission as compared to patients with late-onset NP (48.5% vs 30.8%; p ϭ 0.001). The diagnosis of early-onset NP was made statistically earlier during patients' ICU stay as compared to the diagnosis of late-onset NP (2.1 Ϯ 1.2 days vs 9.9 Ϯ 6.5 days; p Ͻ 0.001). Twenty-three (10.7%) patients with early-onset NP were intubated after the diagnosis of NP as compared with none of the patients with late-onset NP (p Ͻ 0.001). Among patients without NP, 2,356 (72.5%) received antibiotics during their ICU stay. All patients with earlyonset and late-onset NP were treated with antibiotics during their ICU stay. One hundred eighty-three patients (77.9%) with early-onset NP received antibiotics prior to the development of NP as compared to 162 patients (87.6%) with late-onset NP (p ϭ 0.010).
Multiple logistic regression analysis for the entire study cohort demonstrated that increasing APACHE II scores, reintubation, the use of histamine type-2 receptor antagonists, longer durations of mechanical ventilation, and tracheostomy were independently associated with the development of NP (Table 3) . COPD, increasing APACHE II scores, reintubation, and the use of antacids, vasopressors, or histamine type-2 receptor antagonists were independently associated with early-onset NP. Similarly, the use of vasopressors or histamine type-2 receptor antagonists, greater durations of mechanical ventilation, tracheostomy, and the presence of congestive heart failure were found to be independently associated with the development of late-onset NP.
Pathogens Associated With NP
The pathogens associated with nosocomial pneumonia for both early-onset and late-onset NP are shown in Table 4 . P aeruginosa was the most common Gram-negative bacterial pathogen isolated from the respiratory tract in infected patients with both early-onset NP and late-onset NP. S aureus was the most common Gram-positive bacterial pathogen associated with both early-onset and late-onset NP. P aeruginosa was significantly more common among 
Clinical Outcomes
The hospital length of stay was significantly longer for both patients with early-onset NP (33.3 Ϯ 38.2 days; p Ͻ 0.001) and late-onset NP (37.2 Ϯ 26.7 days; p Ͻ 0.001), compared to patients without NP (11.8 Ϯ 12.2 days). Similarly, the ICU length of stay was significantly longer for patients with early-onset NP (10.3 Ϯ 8.3 days; p Ͻ 0.001) and late-onset NP (21.0 Ϯ 13.7 days; p Ͻ 0.001), compared to patients without NP (3.5 Ϯ 3.2 days; Fig 1) . The ICU length of stay was significantly longer for patients with late-onset NP compared to patients with early onset NP (p Ͻ 0.001). The number of acquired organ system derangements was significantly greater for both patients with early-onset NP (2.6 Ϯ 1.5 organ systems; p Ͻ 0.001) and late-onset NP (3.3 Ϯ 1.5 organ systems; p Ͻ 0.001) compared to patients without NP (1.5 Ϯ 1.4 organ systems). The number of acquired organ system derangements was significantly greater for patients with late-onset NP compared to patients with early onset NP (p Ͻ 0.001). The hospital mortality rate was significantly greater for patients with early-onset NP and late-onset NP compared to patients without NP (Fig 2) . 
Risk Factors for Hospital Mortality
Five hundred eighty-nine patients (16.1%) died during their hospitalization. Table 5 shows that the use of vasopressors was the most important independent risk factor for hospital mortality. An increasing number of acquired organ system derangements, the occurrence of NP, the presence of underlying malignancy, the use of corticosteroids, increasing APACHE II scores, and increasing patient age were also identified to be independent predictors of hospital mortality. Additionally, admission to the ICU following a surgical procedure and the use of sucralfate were found to be the independent risk factors favoring hospital survival. Repeating the logistic regression analysis with NP replaced by either earlyonset NP or late-onset NP produced similar results.
Discussion
In this prospective study, we compared patients with early-onset NP to those with late-onset NP and both groups to patients without NP. We identified potential risk factors associated with either earlyonset or late-onset NP. The presence of COPD, reintubation, increasing APACHE II scores, and the use of antacids were independently associated with the occurrence of early-onset NP. Tracheostomy, increasing duration of mechanical ventilation, and the presence of congestive heart failure were independently associated with the development of lateonset NP. We also found that P aeruginosa and S aureus were the most common etiologic pathogens associated with both early-onset and late-onset NP. Additionally, although mortality was similar for patients with early-onset and late-onset NP, those with late-onset NP had significantly longer durations of mechanical ventilation and ICU lengths of stay. Finally, the high mortality rates observed in patients with early-onset NP (37.9%) and late-onset NP (41.1%) appeared to be due primarily to patients' severity of illness at the time of ICU admission, with average APACHE II scores Ͼ 20 for both groups ( Table 1) .
The importance of these observations are that they may influence antimicrobial prescribing practices in the ICU setting. Our findings suggest that antipseudomonal antibiotics and antimicrobial agents directed against ORSA should be prescribed empirically at our institution to patients suspected of having either early-onset or late-onset NP. This may help to reduce the occurrence of inadequate antimicrobial therapy, which has been associated with poorer patient outcomes. [17] [18] [19] [20] [21] The high rate of early-onset NP due to potentially antibiotic-resistant bacteria (eg, P aeruginosa, ORSA, Enterobacter species, Stenotrophomonas maltophilia) may be due, in part, to patients' hospitalization prior to ICU admission as well as the prior use of antibiotics. Over 77% of patients with early-onset NP received antimicrobial therapy prior to the development of this nosocomial infection. Previous investigations have demonstrated a strong association between prior antibiotic use during the same hospitalization and the subsequent development of NP, particularly NP due to potentially antibiotic-resistant pathogens. 8, [22] [23] [24] [25] These data also highlight the importance of having hospitalspecific or unit-specific microbiological data to help guide the empiric therapy of suspected nosocomial infections.
Our findings are consistent with those reported from other countries. Heyland and colleagues 26 found that patients with ventilator-associated pneumonia (VAP) in Canada had longer lengths of stay in the ICU and a greater risk of hospital mortality compared to patients without VAP. They also demonstrated that the timing of VAP defined as earlyonset (Ͻ 7 days) and late-onset (Ͼ 7 days) did not influence mortality. This is also consistent with the findings of Mosconi and coworkers, 27 who compared patients with early-onset and late-onset NP in Italy and found similar risks of death in both groups. One potential explanation for these findings, as suggested by our current investigation, is that patients with early-onset NP and late-onset NP may have similar rates of infection with high-risk pathogens (eg, P aeruginosa, Acinetobacter species, ORSA) that are associated with higher rates of attributable hospital mortality. 23, 28 According to a recent American Thoracic Society consensus statement, early-onset NP (ie, developing Ͻ 5 days after hospital admission) is most often due to core microorganisms, which include enteric Gram-negative bacilli, H influenza, and Gram-positive organisms, such as OSSA and S pneumoniae. 4 Not included among these core micro-organisms are highly resistant Gram-negative organisms, such as P aeruginosa and Acintobacter species, and ORSA. These authors recommended monotherapy for the treatment of early-onset NP using either a secondgeneration cephalosporin, a nonpseudomonal thirdgeneration cephalosporin, or a ␤-lactam/␤-lactamase inhibitor combination. 4 Our current findings suggest that at our institution, such therapeutic recommendations would result in undertreating patients with early-onset NP who are infected with ORSA or P aeruginosa.
For patients who develop late-onset NP (ie, after being hospitalized for 5 days), the most commonly encountered pathogens are reported to be potentially antibiotic-resistant Gram-negative bacteria including P aeruginosa and Acintobacter species, as well as S aureus. 4 The recommendations of the American Thoracic Society for the empirical treatment of these pathogens include the use of combination antimicrobial therapy with drugs that are active against P aeruginosa (antipseudomonal penicillins, some third-generation cephalosporins, the monobactam aztreonam, antipseudomonal ␤-lactam/ ␤-lactamase inhibitor combinations, aminoglycosides, and the flouroquinolone ciprofloxacin) and vancomycin for severely ill patients with suspected ORSA infection. 4 Our findings suggest that these antimicrobial recommendations should also apply to patients with early-onset NP when significant rates of early-onset NP are demonstrated to be due to potentially antibiotic-resistant bacteria. Such pathogens should most commonly be observed in patients with risk factors for infection due to antibioticresistant bacteria including prior antibiotic therapy and prolonged mechanical ventilation. 8 The observed differences in potential risk factors for patients with early-onset NP and late-onset NP appear to be markers for aspiration and aerodigestive tract colonization. Both of these processes have been linked to the pathogenesis of NP. 9 Reintubation was the most important risk factor for patients with early-onset NP. This suggests that aspiration during reintubation may have contributed to the development of this infection. 29 Tracheostomy was the most important risk factor for late-onset NP, which also supports a potential role for aspiration in this group of patients. 30 The use of antacids in patients with early-onset NP and histamine type-2 receptor antagonists in patients with late-onset NP suggests that colonization of the stomach with pathogenic bacteria may have contributed to the development of NP in some patients. However, due to the observational design of our study, we cannot exclude the possibility that the identified risk factors for NP are simply markers of severity of illness. Interestingly, prior antibiotic therapy was not found to be an independent risk factor for NP in this cohort. This may be explained by the high overall rate of antibiotic administration in this group of patients.
Our study has several limitations. First, our patient population may not be similar to those at other institutions. Therefore, our results may not be applicable to ICUs with lower rates of NP due to ORSA and P aeruginosa. Additionally, the high incidence of hospitalization prior to ICU admission and prior exposure to antibiotics among our patients may not be representative of practices at other institutions. One recent multicenter study found significant variability among the bacterial pathogens associated with VAP within four European ICUs. 31 Antibiotic-resistant bacteria, including Acinetobacter species and P aeruginosa, were associated with VAP occurring within 7 days of mechanical ventilation at two of the ICUs examined. This supports the existence of variability between hospitals in terms of the etiologic agents associated with NP and VAP. Second, we used a clinical diagnosis of NP that could be established at the bedside without requiring invasive diagnostic procedures. 22, 32 Although some authors have warned that the incidence of NP may be overestimated when clinical criteria alone are used, 12,33 our incidence of NP was similar to that reported by other investigators employing bronchoscopic methods for the diagnosis of NP. 34, 35 A recent study also highlighted the limited correlation observed between quantitative cultures obtained with bronchoscopic techniques (ie, protected specimen brush, BAL) and postmortem histologic examination of the lung. 36 This lack of correlation has been, in part, attributed to the influence of antimicrobial therapy resulting in both false-negative culture results in patients with NP 37, 38 and false-positive culture results in patients without clinical manifestations of NP who are colonized with antibioticresistant bacteria. 39 Such discrepancies have lead some authors to suggest that clinical definitions for the presence or absence of NP can be employed for "high-quality" patient care and clinical investigations. 40 Despite the above-noted limitations, our large sample size allowed us to identify potential risk factors for both early-onset and late-onset NP. More importantly, our results suggest that individual hospitals should determine their most appropriate antimicrobial regimens for the empiric treatment of early-onset and late-onset NP based on the prevailing local etiologic agents associated with NP. This is further supported by the demonstrated variability that can exist between institutions in terms of the pathogens associated with VAP or NP. 31 The use of hospital-specific or unit-specific microbiological information can potentially influence local antibiotic prescribing practices in order to reduce the administration of inadequate or ineffective antimicrobial treatment.
